Skip to main content

Table 2 Characteristics and results of studies on within-subject variability of the IFN-γ response

From: Interferon-gamma release assays for the tuberculosis serial testing of health care workers: a systematic review

Study (Year of publication)

Country

IGRA(s) used

Subjects (total number of tests)

Visits (Days)

Summary of results

Studies in countries with a high incidence of TB (≥ 100 per 100,000 population and year)*

Veerapathran et al. (2008) [21]

India

QFT

14 (56)

0, 3, 9, 12

Over a two-week period, two out of 14 subjects (14%) had a QFT reversion. Overall, reproducibility of the quantitative results was moderate. A non-significant 30% reduction in mean IFN-y response was observed between visits. An increase of up to 16% in IFN-γ concentration was within the expected within-subject variability.

Van Zyl-Smit et al. (2009) [20]

South Africa

QFT T-SPOT

26# (88)

0, 7, 14, 21

Over a three-week period seven out of 26 volunteers had a conversion or a reversion (1x QFT, 6x T-SPOT). A change in mean IFN-γ response of ± 80% (QFT) or ± 3 SFCs accounted for 95% of the within-subject variability.

Detjen et al. (2009) [43]

South Africa

QFT

27 (54)

0, 3

Over a three-day period no qualitative changes in the QFT results were noted in 15 subjects, but a partly substantial within-subject variability in IFN-γ response was observed (intra-class correlation = 0.80).

Studies in countries with a low incidence of TB (< 20 per 100,000 population and year)

Belknap et al. (2009)[24]

USA

QFT T-SPOT

117 (234)

0, 7–21

Over a three-week period seven out of 117 (6%) and eight out of 105 (8%) had a conversion or reversion with QFT or T-SPOT respectively.

Ringshausen et al. (2011) [44]

Germany

QFT T-SPOT

35 (158)

0, 7, 14, 21, 28

Changes of ± 70% (QFT) and ± 60% (T-SPOT) in mean IFN-γ response accounted for 95% of the within-subject variability. Inconsistent results were significantly more frequent with QFT (29%) than with T-SPOT (9%).

  1. * In studies conducted in countries with a high TB incidence occult TB exposure during the study cannot be ruled out with certainty.
  2. # Health care workers and healthy (“low risk”) subjects.
  3. Published abstract with updated preliminary results presented by Daley C. (on behalf of the CDC TB Epidemiological Studies Consortium). Evaluation of Interferon-γ Release Assays in the Diagnosis of Latent TB Infection in U.S. Healthcare Workers: Preliminary Results of Task Order #18. May 31 2009; 2nd Global Symposium on IGRAs, Dubrovnik, Croatia.
  4. Abbreviations: IGRA = interferon-γ release assay; IFN-γ = interferon-γ; QFT = QuantiFERON-TB Gold In-Tube; SFC = spot-forming cell; TB = tuberculosis; T-SPOT = T.SPOT.TB.